ABclonal: ABclonal Biotechnology Closes $93M Series C Financing

ABclonal Biotechnology, a Woburn, Mass.-based global life science tools and services provider, completed its $92.9m Series C financing. The round was led by Sequoia Capital China and LYFE Capital, with participation from Sigma Square Capital, Kinghall Ventures, and Lucion Capital. Led by Zack Wu, CEO, ABclonal Biotechnology is the parent company of ABclonal Technology, a Massachusetts-based life science [...] The post ABclonal Biotechnology Closes $93M Series C Financing appeared first on FinSMEs.